Modular nanotransporters: A versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting 125I

EJNMMI Research

Volumn 2, Issue 1, 2012, Pages 1-10

  Slastnikova, Tatiana A ^a,b   Koumarianou, Eftychia ^c   Rosenkranz, Andrey A ^a,b   Vaidyanathan, Ganesan ^c   Lupanova, Tatiana N ^a,b   Sobolev, Alexander S ^a,b   Zalutsky, Michael R ^c  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Auger radiotherapy; EGFR; Iodine 125; Modular nanotransporters; Targeted delivery

Indexed keywords

ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; IODINE 125; MODULAR NANOTRANSPORTER; N SUCCINIMIDYL 4 GUANIDINOMETHYL 3 IODOBENZOATE I 125; NANOCARRIER; UNCLASSIFIED DRUG;

ARTICLE; AUGER RADIOTHERAPY; BINDING AFFINITY; CANCER CELL; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CARCINOMA CELL; CELL NUCLEUS; CELL SURFACE; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RECEPTOR BINDING; DRUG TRANSPORT; ENDOSOME; GLIOMA CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; INTERNALIZATION; ISOTOPE LABELING; MEMBRANE BINDING; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; SQUAMOUS CELL CARCINOMA;

EID: 84875356905     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-2-59     Document Type: Article

References (29)

1. Buchegger F, Perillo-Adamer F, Dupertuis YM, Delaloye AB: Auger radiation targeted into DNA: a therapy perspective. Eur J Nucl Med Mol Imaging 2006, 33:1352-1363.
2. 125I-labeled thymidine analogue 5-iodo-40-thio-20-deoxyuridine. Nucl Med Biol 2011, 38:1067-1077.
3. 111In-NLS-trastuzumab and are radiosensitized by methotrexate. J Nucl Med 2008, 49:1498-1505.
4. Rosenkranz AA, Lunin VG, Gulak PV, Sergienko OV, Shumiantseva MA, Voronina OL, Gilyazova DG, John AP, Kofner AA, Mironov AF, Jans DA, Sobolev AS: Recombinant modular transporters for cell-specific nuclear delivery of locally acting drugs enhance photosensitizer activity. FASEB J 2003, 17:1121-1123.
5. Gilyazova DG, Rosenkranz AA, Gulak PV, Lunin VG, Sergienko OV, Khramtsov YV, Timofeyev KN, Grin MA, Mironov AF, Rubin AB, Georgiev GP, Sobolev AS: Targeting cancer cells by novel engineered modular transporters. Cancer Res 2006, 66:10534-10540.
6. Slastnikova TA, Rosenkranz AA, Gulak PV, Schiffelers RM, Lupanova TN, Khramtsov YV, Zalutsky MR, Sobolev AS: Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery. Int J Nanomedicine 2012, 7:467-482.
7. Rosenkranz AA, Vaidyanathan G, Pozzi OR, Lunin VG, Zalutsky MR, Sobolev AS: Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At. Int J Radiat Oncol Biol Phys 2008, 72:193-200.
8. Nicholson RI, Gee JM, Harper ME: EGFR and cancer prognosis. Eur J Cancer 2001, 37(Suppl 4):S9-S15.
9. Cornelissen B, Vallis KA: Targeting the nucleus: an overview of Augerelectron radionuclide therapy. Curr Drug Discov Technol 2010, 7:263-279.
10. Velikyan I, Sundberg AL, Lindhe O, Hoglund AU, Eriksson O, Werner E, Carlsson J, Bergström M, Långström B, Tolmachev V: Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors. J Nucl Med 2005, 46:1881-1888.
11. Werner MH, Humphrey PA, Bigner DD, Bigner SH: Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol 1988, 77:196-201.
12. Vaidyanathan G, Zalutsky MR: Synthesis of N-succinimidyl 4-guanidinomethyl-3-[*I]iodobenzoate: a radio-iodination agent for labeling internalizing proteins and peptides. Nat Protoc 2007, 2:282-286.
13. Williams JA, Bailey AC, Roach E: Temperature dependence of high-affinity CCK receptor binding and CCK internalization in rat pancreatic acini. Am J Physiol 1988, 254:G513-G521.
14. Fell PL, Hudson AJ, Reynolds MA, Usman N, Akhtar S: Cellular uptake properties of a 20-amino/20-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA. Antisense Nucleic Acid Drug Dev 1997, 7:319-326.
15. Marino M, Andrews D, Brown D, McCluskey RT: Transcytosis of retinolbinding protein across renal proximal tubule cells after megalin (gp 330)-mediated endocytosis. J Am Soc Nephrol 2001, 12:637-648.
16. Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, Hung MC: Nuclearcytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem 2006, 98:1570-1583.
17. Howell RW: Radiation spectra for Auger-electron emitting radionuclides: report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1992, 19:1371-1383.
18. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV: MIRD Cellular S Values. Reston: Society of Nuclear Medicine; 1997.
19. 125I-labeled DNA intercalator in mammalian cells. Radiat Res 1989, 118:283-294.
20. 211At]astato-20-deoxyuridine in human cancer cells. Int J Radiat Biol 1997, 72:79-90.
21. Mairs RJ, Boyd M: Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors. Semin Nucl Med 2011, 41:334-344.
22. Kassis AI: Molecular and cellular radiobiological effects of Auger emitting radionuclides. Radiat Prot Dosimetry 2011, 143:241-247.
23. Michel RB, Castillo ME, Andrews PM, Mattes MJ: In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting lowenergy electrons. Clin Cancer Res 2004, 10:5957-5966.
24. Govindan SV, Goldenberg DM, Elsamra SE, Griffiths GL, Ong GL, Brechbiel MW, Burton J, Sgouros G, Mattes MJ: Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters. J Nucl Med 2000, 41:2089-2097.
25. 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors. Nucl Med Biol 2010, 37:105-115.
26. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl Med 2000, 41:429-438.
27. 111In in human myeloid leukemia cells. J Nucl Med 2006, 47:827-836.
28. Kodiha M, Stochaj U: Nuclear transport: a switch for the oxidative stresssignaling circuit? J Signal Transduct 2012, 201(2):208650.
29. Ciechanover A: Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Medicina (B Aires) 2010, 70:105-119.